5 Reasons AstraZeneca Stock Can Rise In 2024

hapabapa Oncology-focused pharmaceuticals company AstraZeneca PLC (NASDAQ:AZN) has had an underwhelming past year at the stock markets, with just a 3% price rise. However, the limited price change detracts from the fundamental positives of the stock. Here, I look at 5 aspects that set it apart and can provide impetus for price upside in 2024. Price Chart (Source: Seeking Alpha) #1. Improved revenue guidance after an outlook beating 2023 When analyzing any stock, the future financials are, of course, of key ...